Anika Therapeutics(CH:AKP)
CH:AKP
Anika Therapeutics ownership
Anika Therapeutics (AKP) Ownership - Who Owns Anika Therapeutics?
0 Followers
Anika Therapeutics (AKP) Ownership Overview
- 5.00% Insiders
- 12.02% Mutual Funds
- 4.21% Other Institutional Investors
- 13.55% ETFs
- 65.22% Public Companies and Individual Investors
The ownership structure of Anika Therapeutics (CH:AKP) stock is a mix of institutional, retail, and individual investors. Approximately 29.78% of the company’s stock is owned by Institutional Investors, 5.00% is owned by Insiders, and 65.22% is owned by Public Companies and Individual Investors.
The ownership structure of Anika Therapeutics (CH:AKP) stock is a mix of institutional, retail, and individual investors. Approximately 29.78% of the company’s stock is owned by Institutional Investors, 5.00% is owned by Insiders, and 65.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 04, 2026 | Gary P Fischetti | $41,050 | |
| May 03, 2026 | John Henneman | $73,300 | |
| Apr 29, 2026 | Stephen D. Griffin | $149,816 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Diker Management Llc | CHF559,398 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 1,449,671 | Institution | 10.82% | ― |
| Vanguard | 632,501 | Institution | 4.72% | ― |
| Vanguard Index Funds | 560,282 | Institution | 4.18% | ― |
| Ishares | 455,978 | Institution | 3.40% | ― |
| Dfa | 310,699 | Institution | 2.32% | ― |
| Cheryl Blanchard | 270,530 | Insider | 2.02% | ― |
| Dfa Investment Dimensions Group Inc | 246,228 | Institution | 1.84% | ― |
| Fidelity Salem Street Trust | 141,543 | Institution | 1.06% | ― |
| Fidelity Concord Street Trust | 134,423 | Institution | 1.00% | ― |
| Franklin Value Investors Trust | 129,315 | Institution | 0.97% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 560,282 | Institution | 4.18% | ― |
| Dfa Investment Dimensions Group Inc | 246,228 | Institution | 1.84% | ― |
| Fidelity Salem Street Trust | 141,543 | Institution | 1.06% | ― |
| Fidelity Concord Street Trust | 134,423 | Institution | 1.00% | ― |
| Franklin Value Investors Trust | 129,315 | Institution | 0.97% | ― |
| Vanguard Scottsdale Funds | 77,490 | Institution | 0.58% | ― |
| Tiaa-cref Funds | 52,341 | Institution | 0.39% | ― |
| Mfs Series Trust X | 45,877 | Institution | 0.34% | ― |
| Schwab Capital Trust | 37,027 | Institution | 0.28% | ― |
| Columbia Funds Series Trust I | 29,060 | Institution | 0.22% | ― |
FAQ
Who Owns Anika Therapeutics (CH:AKP)?
According to the latest TipRanks data, approximately 29.78% of the company's stock is held by institutional investors, 5.00% is held by insiders, and 65.22% is held by public companies and individual investors.
What percentage of Anika Therapeutics (CH:AKP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 29.78% of Anika Therapeutics (CH:AKP) stock is held by institutional investors: 12.02% by mutual funds, 13.55% by ETFs and 4.21% by other institutional investors.
What percentage of Anika Therapeutics (CH:AKP) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.22% of Anika Therapeutics (CH:AKP) stock is held by public companies and individual investors.
Who owns the most shares of Anika Therapeutics (CH:AKP)?
BlackRock, Inc. owns the most shares of Anika Therapeutics (CH:AKP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
